27438188|t|Update on the Role of Cardiac Magnetic Resonance in Acquired Nonischemic Cardiomyopathies
27438188|a|Cardiomyopathies refer to a variety of myocardial disorders without underlying coronary artery disease, valvular heart disease, hypertension, or congenital heart disease. Several imaging modalities are available, but cardiac magnetic resonance (CMR) has now established itself as a crucial imaging technique in the evaluation of several cardiomyopathies. It not only provides comprehensive information on structure and function, but also can perform tissue characterization, which helps in establishing the etiology of cardiomyopathy. CMR is also useful in establishing the diagnosis, providing guidance for endomyocardial biopsy, accurate quantification of function, volumes, and fibrosis, prognostic determination, risk stratification, and monitoring response to therapy. In this article, we review the current role of CMR in the evaluation of several acquired nonischemic cardiomyopathies, particularly focusing on recent advances in knowledge. We also discuss in detail a select group of common acquired nonischemic cardiomyopathies.
27438188	0	6	Update	T079	C1519814
27438188	22	48	Cardiac Magnetic Resonance	T060	C0412692
27438188	52	60	Acquired	T080	C0439661
27438188	61	89	Nonischemic Cardiomyopathies	T047	C0878544
27438188	90	106	Cardiomyopathies	T047	C0878544
27438188	129	149	myocardial disorders	T047	C3241958
27438188	158	168	underlying	T080	C0205275
27438188	169	192	coronary artery disease	T047	C0010054
27438188	194	216	valvular heart disease	T047	C0018824
27438188	218	230	hypertension	T047	C0020538
27438188	235	259	congenital heart disease	T019	C0152021
27438188	269	287	imaging modalities	T169	C1275506
27438188	307	333	cardiac magnetic resonance	T060	C0412692
27438188	335	338	CMR	T060	C0412692
27438188	380	397	imaging technique	T060	C0079595
27438188	405	415	evaluation	T058	C0220825
27438188	427	443	cardiomyopathies	T047	C0878544
27438188	466	479	comprehensive	T080	C1880156
27438188	480	491	information	T078	C1533716
27438188	495	504	structure	T082	C0678594
27438188	509	517	function	T169	C0542341
27438188	532	539	perform	T169	C0884358
27438188	540	546	tissue	T024	C0040300
27438188	547	563	characterization	T052	C1880022
27438188	580	592	establishing	T080	C0443211
27438188	597	605	etiology	T169	C1314792
27438188	609	623	cardiomyopathy	T047	C0878544
27438188	625	628	CMR	T060	C0412692
27438188	647	659	establishing	T080	C0443211
27438188	664	673	diagnosis	T033	C0011900
27438188	675	684	providing	T052	C1999230
27438188	685	693	guidance	T061	C1959633
27438188	698	719	endomyocardial biopsy	T060	C0189785
27438188	721	729	accurate	T080	C0443131
27438188	730	744	quantification	T081	C1709793
27438188	748	756	function	T169	C0542341
27438188	758	765	volumes	T081	C0449468
27438188	771	779	fibrosis	T046	C0016059
27438188	781	791	prognostic	T170	C0220901
27438188	792	805	determination	T080	C0521095
27438188	807	811	risk	T078	C0035647
27438188	812	826	stratification	T062	C1514983
27438188	832	862	monitoring response to therapy	T058	C1822578
27438188	872	879	article	T170	C0282420
27438188	884	890	review	T078	C1552617
27438188	895	902	current	T079	C0521116
27438188	911	914	CMR	T060	C0412692
27438188	922	932	evaluation	T058	C0220825
27438188	944	952	acquired	T080	C0439661
27438188	953	981	nonischemic cardiomyopathies	T047	C0878544
27438188	1008	1014	recent	T079	C0332185
27438188	1027	1036	knowledge	T170	C0376554
27438188	1066	1078	select group	T098	C1257890
27438188	1089	1097	acquired	T080	C0439661
27438188	1098	1126	nonischemic cardiomyopathies	T047	C0878544